What is the safest way to check current Setmelanotide pricing?

Use official brand pages first, then confirm the exact cash-pay or insured amount with the prescribing service and dispensing pharmacy.

Does insurance always cover Setmelanotide?

No. Coverage depends on the specific plan, indication, and whether prior authorization is approved. Some plans may require step therapy or documentation of medical necessity.

Are there manufacturer savings programs for Setmelanotide?

Many branded peptide therapies offer savings cards or patient assistance programs. Eligibility typically requires commercial insurance and may exclude government programs like Medicare or Medicaid.

Structured page family:Cost guide

Setmelanotide Cost Guide: Insurance, Cash Pay, and Savings

In the United States, Setmelanotide costs depend on brand, pharmacy, insurance design, and whether the patient qualifies for manufacturer savings programs.

Active Market

This page is designed for US treatment decisions and uses US-first pricing and savings sources.

Official pricing

Verify current pricing directly on official Imcivree pages before starting, because list pricing, self-pay offers, and eligibility terms can change.

Cash-pay reality

Official cash-pay pricing varies by pharmacy and dose. Contact multiple pharmacies or use a prescription discount service for current rates.

Insurance coverage

Commercial coverage for Setmelanotide varies by plan and indication. Prior authorization is commonly required.

Savings and coupons

Manufacturer savings programs may reduce out-of-pocket cost for eligible commercially insured patients.

Prior Authorization

Prior authorization is common and may require documentation of diagnosis, prior treatments, and clinical need.

Price Breakdown

List price (monthly)

~$15,000-$20,000/month

Average wholesale price

~$14,000-$19,000/month

Pharmacy acquisition estimate

~$13,000-$17,000/month

Typical negotiated rate

~$10,000-$15,000/month

Price per dose

~$500 per 1-3 mg daily dose

Annual cost at list price

~$180,000-$240,000

Pharmacy Price Comparison

Pharmacy	Price Range	Notes
Specialty pharmacy	$15,000-$20,000/month	Required

Insurance Coverage Landscape

Commercial plans

~60-70% with genetic diagnosis

Medicare Part D

Case-by-case; rare disease protocols

Medicaid

Some states cover with extensive documentation

VA coverage

Case-by-case

TRICARE

Case-by-case

Employer plan typical tier

Tier 5 specialty; coinsurance or max out-of-pocket

Prior Authorization Guide

Required Documentation

•Genetic test confirming biallelic POMC, PCSK1, or LEPR deficiency
•Age ≥6 years
•Severe obesity with hyperphagia
•Specialist attestation

Common Denial Reasons

•No genetic confirmation
•MC4R mutation (not responsive)
•Common polygenic obesity
•Age outside approved range

Appeal Template Points

•Ultra-rare genetic disease
•FDA-approved indication
•Genetic test attached
•No alternative therapy
•Life-transforming potential

Expected timeline: 2-4 weeks (complex cases)

Savings Programs and Patient Assistance

Rhythm PAP

manufacturer

Eligibility: Uninsured/underinsured

Savings: May provide at no cost

Income limit: Case-by-case

Enrollment: complex

Case management included

Copay assistance

copay

Eligibility: Commercially insured

Savings: May reduce to $0

Income limit: None

Enrollment: moderate

Annual cap

Generic and Biosimilar Status

No generic currently available

Expected: No generic expected

Cost by Dose

Dose/Regimen	Monthly	Annual
2-3 mg daily	$15,000-$20,000	$180,000-$240,000

Annual Cost Projection

Year 1

$0-$240,000

Year 2

$0-$240,000

Year 3

$0-$240,000

Assumptions

•Ultra-rare indication
•Insurance variable

Cost-Saving Strategies

1.Genetic testing and specialist documentation are critical for coverage
2.Apply for manufacturer PAP immediately if any coverage gaps
3.Work with patient advocate for appeals
4.Explore state high-risk pools or rare disease programs

International Price Comparison

Country	Price Range	Notes
UK	NHS negotiated (confidential)	NICE evaluation

Need help comparing setmelanotide paths?

Use the provider matcher to package treatment interest, insurance, budget, urgency, and state context before you commit to a prescribing path.

Find a setmelanotide provider

Next Step

Use the cost calculator

Use provider matching when you need help comparing insured and self-pay treatment paths.

Open tool →

Retention Path

Join the Setmelanotide tracker waitlist

Capture refill timing, weekly dose history, and symptom notes in one planned workflow.

View tracker landing →

Trust Summary

Reviewed 2026-04-27 by PeptideScholar editorial review. This page currently cites 3 official sources.

Pricing, savings eligibility, and coverage rules can change quickly. Verify all current figures and terms directly on official brand pages before acting.

Setmelanotide Cost FAQ

Sources

1. Proopiomelanocortin Deficiency Treated with a Melanocortin-4 Receptor Agonist.
N Engl J Med • 2016
Claim type: review
View source →
2. Setmelanotide in patients aged 2-5 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial.
Lancet Diabetes Endocrinol • 2025
Claim type: clinical
View source →
3. FDA Information on Setmelanotide
FDA • 2026
Claim type: regulatory
View source →

This content is for informational purposes only and does not constitute medical advice.